
Pantavid-IV Injection
Marketer
Getron Pharmaceuticals
Salt Composition
Pantoprazole (40mg)
Overview Pantavid-IV Injection
Intravenous Pantavid reduces gastric acid secretion. It treats stomach and intestinal conditions such as gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, relieving symptoms and promoting healing. This proton pump inhibitor (PPI) is also used prophylactically against stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risk. Administered intravenously by a healthcare professional, it's prescribed only when intravenous delivery is deemed superior to oral medication. Dosage and treatment duration are determined by your physician based on your individual needs and response. Consistent use as directed is crucial, even with rapid symptom improvement. Lifestyle modifications, including smaller, more frequent meals and avoidance of caffeine, spicy foods, and fatty foods, can enhance treatment efficacy. Common, usually mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year or at high doses, may increase fracture risk; discuss bone health strategies, such as calcium and vitamin D supplementation, with your doctor. Pantavid-IV is contraindicated in certain individuals. Inform your physician of severe hepatic impairment, HIV medication use, prior allergic reactions to similar drugs, or pre-existing osteoporosis before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Alcohol should be avoided due to its acid-stimulating effects. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Pantavid-IV Injection
The provided text is "undefined". Therefore, no rephrasing is possible.
Uses of Pantavid-IV Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pantavid-IV Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Pantavid-IV Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pantavid-IV Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pantavid-IV Injection works:
Stomach acid production is decreased by the proton pump inhibitor Pantavid-IV Injection, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Pantavid-IV Injection should not be used concurrently with alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Pantavid-IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Intravenous Pantavid administration during lactation appears to pose minimal risk to the infant, based on currently available, albeit limited, human data.
DrivingCONSULT YOUR DOCTOR
Pantavid-IV Injection's effect on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Pantavid-IV Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
For patients exhibiting severe hepatic impairment, Pantavid-IV Injection requires careful administration. Dosage modification of Pantavid-IV Injection might be necessary. Physician consultation is advised.
What if you forget to take Pantavid-IV Injection :
Omit a Pantavid-IV Injection dose? Seek your physician's advice.
Facts to Know About Pantavid-IV Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
| Behavior Class | PPIs (proton pump inhibitors) |
